Announcing the results of the 2026 INFORMS Board of Directors election and the new board for 2027.
INFORMS has named 12 distinguished leaders as the 2026 class of INFORMS Fellows, one of the highest honors in the profession.
Most medical devices do not hit the market through rigorous safety testing but by being deemed similar enough to something already approved—the “predicate” device through a mechanism known as the FDA’s 510(k) pathway. But similar is not a synonym for safe. While the assumption may be that substantial equivalence is a reasonable stand-in for a safety review, a share of devices cleared with this method still get recalled, and the FDA spends valuable time reviewing devices the same way, regardless of how risky it is on paper.
An audio journey of how data and analytics save lives, save money and solve problems.
Jeff Cohen
Chief Strategy Officer
INFORMS
Catonsville, MD
[email protected]
443-757-3565
Explore our resources for multiple topics including:
The hunt for a COVID-19 vaccine is heating up. Scientists and pharmaceutical companies globally are researching and developing around 100 vaccine candidates, with at least 10 currently in early phases of human testing, according to the World Health Organization. The U.S. government has narrowed its vaccine candidate list to seven, NPR reported.
The United States and South Korea announced its first case of coronavirus on the same day. In the following months South Korea has been widely praised for its response as life has largely returned to normal.
Andrew Revere Sr. flew to Cincinnati last week, visiting his fifth airport since March. His American Airlines flight marked the first time he was told to wear a mask. “I don’t want to make anybody uncomfortable. So, if they say to wear a mask then I’m going to put it on,” said Revere, an Atlanta resident who played pro football in Mexico until the coronavirus pandemic put an end to his season on March 14.
Lockdowns implemented in some countries to reduce transmission of the coronavirus were extremely effective at controlling its rapid spread and saved millions of lives, two new studies suggest. Shutdowns prevented or delayed an estimated 531 million coronavirus infections across six countries — China, South Korea, Iran, Italy, France and the United States — researchers from the University of California, Berkeley report June 8 in Nature.
The great challenge of something such as COVID-19 is that we don’t have the time to do decades of research to understand the effectiveness — or lack of effectiveness — of any given approach. We have to act. That means, though, that we could be “successful” at handling COVID-19 yet still fail society due to unmeasured impacts.
OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.
Access OR/MS Today Magazine
Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.
Access Analytics Magazine